Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MIMEDX GROUP, INC.MDXG · Entity 5271 | Chief Financial Officer | July 02, 2026 | July 07, 2026 |
| Orthofix Medical Inc.OFIX · Entity 1975 | CFO | April 11, 2022 | April 13, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MIMEDX GROUP, INC.
Report date July 02, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 399,566 |
Reported balance
After 2026-07-02 transaction · row 1
1 source rowRow 1 · 2026-07-02 · Tax withholding · Disposed 12,749 · Balance 399,566 F1: Shares withheld for payment of tax liability upon vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of tax liability upon vesting of restricted stock units.
Orthofix Medical Inc.
Report date April 11, 2022 · Filed April 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 107,679 |
Reported balance
After 2022-04-11 transaction · row 1
1 source rowRow 1 · 2022-04-11 · Grant · Acquired 14,937 · Balance 107,679 F1: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and forth anniversaries of the grant date, April 11, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and forth anniversaries of the grant date, April 11, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 02, 2018 Filed Nov 6, 2018 21:27 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 200 | $61.84 | $12,368.00 |
DisclosureSEC source: 0001209191-18-057399 · doc4.xml · nonDerivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,311 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2018. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.81 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 21:27 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 5,857 | $61.23 | $358,635.82 |
DisclosureSEC source: 0001209191-18-057399 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,511 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2018. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.76 to $61.75, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 20:29 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 3,949 | $55.65 | $219,753.95 |
DisclosureSEC source: 0001209191-18-054970 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,368 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2018. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.10 to $56.04, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 20:37 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 590 | $56.29 | $33,211.10 |
DisclosureSEC source: 0001209191-18-054398 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,317 Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 23:16 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Tax withholdingCommon Stock | 245 | $53.35 | $13,070.75 |
DisclosureSEC source: 0001209191-18-049966 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,907 Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 22:30 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantPerformance Share Units · Derivative | 7,385 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023263 · doc4.xml · derivative · entry 3 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,385 Underlying: Common Stock · 7,385 shares Expires 2021-04-02 F3 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 2, 2018 to April 2, 2021. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of April 2, 2018, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 22:30 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantStock Option (right to buy) · Derivative | 13,109 | $0.00 Strike: $56.87 | $0.00 |
DisclosureSEC source: 0001209191-18-023263 · doc4.xml · derivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,109 Underlying: Common Stock · 13,109 shares Expires 2028-04-02 F2 · derivative.exercise_date: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 2, 2018. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 22:30 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 3,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023263 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,870 F1 · shares: Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 2, 2018. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 20:36 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon stock | 7,353 | $49.46 | $363,688.94 |
DisclosureSEC source: 0001209191-17-052617 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,743 F1 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.16 to $49.685, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 22:01 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantPerformance Share Units · Derivative | 7,592 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-044656 · doc4.xml · derivative · entry 3 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,592 Underlying: Common Stock · 7,592 shares Expires 2020-07-03 F3 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as July 3, 2017 to July 3, 2020. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of July 3, 2017, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 22:01 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantStock Option (right to buy) · Derivative | 13,248 | $0.00 Strike: $46.10 | $0.00 |
DisclosureSEC source: 0001209191-17-044656 · doc4.xml · derivative · entry 2 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,248 Underlying: Common Stock · 13,248 shares Expires 2027-07-03 F2 · derivative.exercise_date: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, July 3, 2017. Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 22:01 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 3,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-044656 · doc4.xml · nonDerivative · entry 1 DOUG RICE · CIK 0001618861 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,096 F1 · shares: Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, July 3, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.